Literature DB >> 9237726

Detection of rifampin resistance in Mycobacterium tuberculosis by use of a rapid, simple, and specific RNA/RNA mismatch assay.

K A Nash1, A Gaytan, C B Inderlied.   

Abstract

An adaption of an RNA/RNA duplex, base pair-mismatch assay is capable of detecting rifampin resistance in Mycobacterium tuberculosis. The specificity and sensitivity of the mismatch assay in detecting rifampin resistance were 100% and 96%, respectively, when tested against 46 rifampin-resistant and rifampin-susceptible strains of M. tuberculosis. By use of a range of mycobacterial and nonmycobacterial prokaryote pathogens, the mismatch assay was shown to be specific for M. tuberculosis and Mycobacterium bovis. The assay is cost-effective compared with DNA sequencing and other molecular methods and is simple to perform and interpret. Furthermore, the assay can return a result within 24 h after receipt of an isolated organism and potentially can be used directly with smear-positive specimens.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9237726     DOI: 10.1086/517283

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  12 in total

1.  Evaluation of the invader assay, a linear signal amplification method, for identification of mutations associated with resistance to rifampin and isoniazid in Mycobacterium tuberculosis.

Authors:  R C Cooksey; B P Holloway; M C Oldenburg; S Listenbee; C W Miller
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

Review 2.  Modern laboratory diagnosis of mycobacterial infections.

Authors:  S A Watterson; F A Drobniewski
Journal:  J Clin Pathol       Date:  2000-10       Impact factor: 3.411

3.  Temperature-mediated heteroduplex analysis performed by using denaturing high-performance liquid chromatography to identify sequence polymorphisms in Mycobacterium tuberculosis complex organisms.

Authors:  Robert C Cooksey; Glenn P Morlock; Brian P Holloway; Josef Limor; Michael Hepburn
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

Review 4.  Molecular detection of antimicrobial resistance.

Authors:  A C Fluit; M R Visser; F J Schmitz
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

5.  Low-stringency single-specific-primer PCR as a tool for detection of mutations in the rpoB gene of rifampin-resistant Mycobacterium tuberculosis.

Authors:  Wania S Carvalho; Silvana Spindola de Miranda; Kátia M Costa; José G V C Araújo; Claudio J Augusto; João B Pesquero; Jorge L Pesquero; Maria A Gomes
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

Review 6.  Molecular diagnostics in tuberculosis.

Authors:  V C C Cheng; W W Yew; K Y Yuen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-11       Impact factor: 3.267

7.  Mutations in the rpoB gene of rifampin-resistant Mycobacterium tuberculosis isolates in Spain and their rapid detection by PCR-enzyme-linked immunosorbent assay.

Authors:  L Garcia; M Alonso-Sanz; M J Rebollo; J C Tercero; F Chaves
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

8.  Identification of rifampin-resistant Mycobacterium tuberculosis strains by hybridization, PCR, and ligase detection reaction on oligonucleotide microchips.

Authors:  V Mikhailovich; S Lapa; D Gryadunov; A Sobolev; B Strizhkov; N Chernyh; O Skotnikova; O Irtuganova; A Moroz; V Litvinov; M Vladimirskii; M Perelman; L Chernousova; V Erokhin; A Zasedatelev; A Mirzabekov
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

9.  Multiplex detection of mutations in clinical isolates of rifampin-resistant Mycobacterium tuberculosis by short oligonucleotide ligation assay on DNA chips.

Authors:  Jiao-Yu Deng; Xian-En Zhang; Hong-Bing Lu; Qiang Liu; Zhi-Ping Zhang; Ya-Feng Zhou; Wei-Hong Xie; Zhi-Jun Fu
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

Review 10.  Molecular diagnostics in tuberculosis: basis and implications for therapy.

Authors:  Seetha V Balasingham; Tonje Davidsen; Irena Szpinda; Stephan A Frye; Tone Tønjum
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.